These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34344966)

  • 1. Immunogenomic pan-cancer landscape reveals immune escape mechanisms and immunoediting histories.
    Mizuno S; Yamaguchi R; Hasegawa T; Hayashi S; Fujita M; Zhang F; Koh Y; Lee SY; Yoon SS; Shimizu E; Komura M; Fujimoto A; Nagai M; Kato M; Liang H; Miyano S; Zhang Z; Nakagawa H; Imoto S
    Sci Rep; 2021 Aug; 11(1):15713. PubMed ID: 34344966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma.
    Dong LQ; Peng LH; Ma LJ; Liu DB; Zhang S; Luo SZ; Rao JH; Zhu HW; Yang SX; Xi SJ; Chen M; Xie FF; Li FQ; Li WH; Ye C; Lin LY; Wang YJ; Wang XY; Gao DM; Zhou H; Yang HM; Wang J; Zhu SD; Wang XD; Cao Y; Zhou J; Fan J; Wu K; Gao Q
    J Hepatol; 2020 May; 72(5):896-908. PubMed ID: 31887370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy.
    Xie F; Zhang J; Wang J; Reuben A; Xu W; Yi X; Varn FS; Ye Y; Cheng J; Yu M; Wang Y; Liu Y; Xie M; Du P; Ma K; Ma X; Zhou P; Yang S; Chen Y; Wang G; Xia X; Liao Z; Heymach JV; Wistuba II; Futreal PA; Ye K; Cheng C; Xia T
    Clin Cancer Res; 2020 Jun; 26(12):2908-2920. PubMed ID: 31911545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer.
    Xiao Y; Ma D; Zhao S; Suo C; Shi J; Xue MZ; Ruan M; Wang H; Zhao J; Li Q; Wang P; Shi L; Yang WT; Huang W; Hu X; Yu KD; Huang S; Bertucci F; Jiang YZ; Shao ZM;
    Clin Cancer Res; 2019 Aug; 25(16):5002-5014. PubMed ID: 30837276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-Cancer HLA Gene-Mediated Tumor Immunogenicity and Immune Evasion.
    Gong X; Karchin R
    Mol Cancer Res; 2022 Aug; 20(8):1272-1283. PubMed ID: 35533264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OMIC signatures to understand cancer immunosurveillance and immunoediting: Melanoma and immune cells interplay in immunotherapy.
    León-Letelier RA; Bonifaz LC; Fuentes-Pananá EM
    J Leukoc Biol; 2019 May; 105(5):915-933. PubMed ID: 30698862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and Immune Silence in Human Cancer.
    Yarmarkovich M; Farrel A; Sison A; di Marco M; Raman P; Parris JL; Monos D; Lee H; Stevanovic S; Maris JM
    Front Immunol; 2020; 11():69. PubMed ID: 32256484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape.
    Eichmüller SB; Osen W; Mandelboim O; Seliger B
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28383653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity.
    Cindy Yang SY; Lien SC; Wang BX; Clouthier DL; Hanna Y; Cirlan I; Zhu K; Bruce JP; El Ghamrasni S; Iafolla MAJ; Oliva M; Hansen AR; Spreafico A; Bedard PL; Lheureux S; Razak A; Speers V; Berman HK; Aleshin A; Haibe-Kains B; Brooks DG; McGaha TL; Butler MO; Bratman SV; Ohashi PS; Siu LL; Pugh TJ
    Nat Commun; 2021 Aug; 12(1):5137. PubMed ID: 34446728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological-based approaches for cancer therapy.
    Barros L; Pretti MA; Chicaybam L; Abdo L; Boroni M; Bonamino MH
    Clinics (Sao Paulo); 2018 Aug; 73(suppl 1):e429s. PubMed ID: 30133560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunoediting eventually proven in humans. Genetics to assist immunotherapy].
    David Fumet J; Ghiringhelli F
    Med Sci (Paris); 2019; 35(8-9):629-631. PubMed ID: 31532373
    [No Abstract]   [Full Text] [Related]  

  • 12. SnapShot: Cancer immunoediting.
    Varanasi SK; Kaech SM; Bui JD
    Cell; 2022 Oct; 185(21):4038-4038.e1. PubMed ID: 36240741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy.
    Davoli T; Uno H; Wooten EC; Elledge SJ
    Science; 2017 Jan; 355(6322):. PubMed ID: 28104840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tackling Resistance to Cancer Immunotherapy: What Do We Know?
    Gondhowiardjo SA; Handoko ; Jayalie VF; Apriantoni R; Barata AR; Senoaji F; Utami IJW; Maubere F; Nuryadi E; Giselvania A
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32911646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies.
    Hartmaier RJ; Charo J; Fabrizio D; Goldberg ME; Albacker LA; Pao W; Chmielecki J
    Genome Med; 2017 Feb; 9(1):16. PubMed ID: 28231819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade.
    Charoentong P; Finotello F; Angelova M; Mayer C; Efremova M; Rieder D; Hackl H; Trajanoski Z
    Cell Rep; 2017 Jan; 18(1):248-262. PubMed ID: 28052254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer group 2D receptor and its ligands in cancer immune escape.
    Duan S; Guo W; Xu Z; He Y; Liang C; Mo Y; Wang Y; Xiong F; Guo C; Li Y; Li X; Li G; Zeng Z; Xiong W; Wang F
    Mol Cancer; 2019 Feb; 18(1):29. PubMed ID: 30813924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells.
    Payne KK; Keim RC; Graham L; Idowu MO; Wan W; Wang XY; Toor AA; Bear HD; Manjili MH
    J Leukoc Biol; 2016 Sep; 100(3):625-35. PubMed ID: 26928306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.
    Hao Y; Li D; Xu Y; Ouyang J; Wang Y; Zhang Y; Li B; Xie L; Qin G
    BMC Bioinformatics; 2019 May; 20(Suppl 7):195. PubMed ID: 31074374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic Characterization of Six Virus-Associated Cancers Identifies Changes in the Tumor Immune Microenvironment and Altered Genetic Programs.
    Varn FS; Schaafsma E; Wang Y; Cheng C
    Cancer Res; 2018 Nov; 78(22):6413-6423. PubMed ID: 30254145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.